https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Vascular-MC.jpg

Implantable Ports Market Analysis | India | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: India
  • Pages: 366
  • Published Date: 1/1/2017
  • Type: MedCore

Currently, the conventional implantable ports segment accounted for the majority of the total implantable ports market. Over the forecast period, the market breakdown is expected to change slightly but conventional devices will still consist of majority of the market.

The implantable ports market will experience high single-digit growth owing to product innovations such as power-injectable implantable ports, dual lumen ports and arm ports. Multi-lumen implantable ports are selling better than previously anticipated. Furthermore, the use of implantable ports in India is on the rise as a spike in the incidence of cancer severely affected the country.

Segments Covered in This Market

  • Conventional Implantable Ports Market
  • Power-Injectable Implantable Ports Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

Of the many companies in the Indian Implantable Port market, C. R. Bard was the leader, followed by B. Braun and Vygon. Bard’s X-Port™ devices have a low-profile design and can be placed in the arm or in the chest of smaller patients. Bard’s PowerPort™ devices are titanium ports that come in a variety of shapes and sizes for use with a wide range of patients. Other notable competitors in this segment include Smiths Medicals.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled India Market Report Suite for Vascular Access Devices and Accessories – MedSuite

Learn More about these product types

TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
INDIA VASCULAR ACCESS DEVICE AND ACCESSORIES MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 9
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
1.1 RESEARCH SCOPE 10
1.2 IDATA’S 9-STEP METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21
DISEASE OVERVIEW 22
2.1 BASIC ANATOMY 22
2.1.1 Human Vascular System 22
2.2 VASCULAR PATHOLOGY AND DISORDERS 23
2.2.1 Cancer 23
2.2.2 End-Stage Renal Disease 24
2.2.3 Diabetes 26
PRODUCT ASSESSMENT 29
3.1 PRODUCT PORTFOLIOS 29
3.1.1 Implantable Port Devices 29
3.1.1.1 Introduction 29
3.1.1.1.1 Implantable Port Patients 29
3.1.1.1.2 Port Implantation Procedures 30
3.1.1.1.3 Port Infusion 30
3.1.1.1.4 Port Maintenance 31
3.1.1.2 AngioDynamics 31
3.1.1.2.1 BioFlo® 31
3.1.1.2.2 LifePort® 31
3.1.1.2.3 Smart Port® CT 31
3.1.1.2.4 TitanPort® 31
3.1.1.2.5 Triumph-1® 32
3.1.1.2.6 Vortex® 32
3.1.1.2.7 Xcela™ Plus 32
3.1.1.3 B. Braun 32
3.1.1.3.1 Celsite® 32
3.1.1.4 Cook Medical 32
3.1.1.4.1 Vital-Port® 32
3.1.1.5 C.R. Bard 33
3.1.1.5.1 PowerPort® 33
3.1.1.5.2 SlimPort® 33
3.1.1.5.3 X-Port™ 33
3.1.1.5.4 Other Port Offerings 33
3.1.1.6 Medcomp 33
3.1.1.6.1 Dignity® 33
3.1.1.6.2 Pro-Fuse® CT 34
3.1.1.7 PFM Medical 34
3.1.1.7.1 T-Port™ 34
3.1.1.7.2 TitaJet™ 34
3.1.1.7.3 Jet Port® 34
3.1.1.7.4 DualPort 34
3.1.1.8 Smiths Medical 34
3.1.1.8.1 P.A.S. PORT® 34
3.1.1.8.2 PORT-A-CATH® 35
3.1.1.9 Teleflex Medical 35
3.1.1.9.1 Polysite® 35
3.2 REGULATORY ISSUES AND RECALLS 36
3.2.1 November 2015 36
3.2.2 October 2015 36
3.2.3 September 2015 37
3.2.4 August 2015 39
3.2.5 July 2015 40
3.2.6 April 2015 42
3.2.7 March 2015 43
3.2.8 February 2015 44
3.2.9 January 2015 44
3.2.10 December 2014 45
3.2.11 October 2014 46
3.2.12 September 2014 47
3.2.13 May 2014 48
3.2.14 April 2014 48
3.2.15 March 2014 49
3.2.16 January 2014 49
3.2.17 December 2013 50
3.2.18 September 2013 51
3.2.19 August 2013 52
3.2.20 June 2013 52
3.2.21 March 2013 53
3.2.22 February 2013 54
3.2.23 December 2012 54
3.2.24 August 2012 54
3.2.25 June 2012 55
3.2.26 May 2012 56
3.2.27 March 2012 57
3.2.28 February 2012 58
3.2.29 January 2012 58
3.3 CLINICAL TRIALS 62
3.3.1 Implantable Port Devices 63
3.4 PRODUCT PIPELINES 65
3.4.1 Alliance Vascular Devices, LLC 65
3.4.1.1 FreeHand Safety Huber Needle® 65
3.4.2 AngioDynamics 65
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation 65
3.4.2.2 Firefly 65
3.4.2.3 BioFlo® PICC Line Extension 66
3.4.2.4 BioFlo® Port Line Extension 66
3.4.2.5 Next Generation BioFlo® PICC 66
3.4.2.6 Next Generation BioFlo® Port 66
3.4.3 Bluegrass Vascular Technologies, Inc. 66
3.4.3.1 Surfacer® Inside-Out™ Access System 66
3.4.4 C.R. Bard 66
3.4.4.1 Chemical-Resistant PICCs 66
3.4.4.2 Novel Advanced Material PICCs 67
3.4.4.3 PowerGlide® Pro Midline 67
3.4.4.4 AccuCath® 67
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter 67
3.4.4.6 Site~Rite® 8 Ultrasound System 67
3.4.5 M. C. Johnson 67
3.4.5.1 PICC Securement Device 67
3.4.6 Nipro Medical 68
3.4.6.1 Shielding Safety Needle 68
3.4.6.2 Safety Syringe 68
3.4.6.3 Safety PIVC 68
3.4.7 Parasol Medical 68
3.4.7.1 Catheter Securement Device 68
3.4.8 PAVmed Inc. 68
3.4.8.1 NextCath™ 68
3.4.9 Phase One Medical 68
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter 68
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter 69
3.4.10 Prodigy Diabetes Care, LLC. 69
3.4.10.1 Insulin Pen Needles 69
3.4.11 Sharklet Technologies, Inc. 69
3.4.11.1 Sharklet™ Central Venous Catheter 69
3.4.12 Starboard Medical 69
3.4.12.1 Catheter Securement Devices 69
3.4.13 Teleflex Medical 70
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System 70
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports 70
3.4.14 Vascular Access Technologies, Inc. 70
3.4.14.1 SAFECVAD™ 70
IMPLANTABLE PORT MARKET 71
4.1 MARKET OVERVIEW 71
4.2 MARKET ANALYSIS AND FORECAST 75
4.2.1 Total Implantable Port Market 75
4.2.2 Conventional Implantable Port Market 77
4.2.3 Power-Injectable Implantable Port Market 79
4.3 DRIVERS AND LIMITERS 81
4.3.1 Market Drivers 81
4.3.2 Market Limiters 81
4.4 COMPETITIVE MARKET SHARE ANALYSIS 83
ABBREVIATIONS 85
APPENDIX: COMPANY PRESS RELEASES 86
The "India Market Report Suite for Vascular Access Devices and Accessories 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Teleflex Medical
Poly Medicure
B. Braun
Becton Dickinson
C. R. Bard
Covidien
Smiths Medical
Others include: Cardinal Health, Cook Medical, GE Healthcare, Manohar International, Medcomp, Medikit, Covidien, Nipro Medical, PFM Medical, Poly Medicure Limited, Terumo, Toshiba, Vygon, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Vascular Access Device and Accessories Market by Segment, India, 2013 – 2023 2
Chart 1 2: Vascular Access Device and Accessories Market by Segment, India, 2016 & 2023 3
Chart 4 1: Implantable Port Market by Segment, India, 2013 – 2023 73
Chart 4 2: Implantable Port Market Breakdown, India, 2016 74
Chart 4 3: Implantable Port Market Breakdown, India, 2023 74
Chart 4 4: Total Implantable Port Market, India, 2013 – 2023 76
Chart 4 5: Conventional Implantable Port Market, India, 2013 – 2023 78
Chart 4 6: Power-Injectable Implantable Port Market, India, 2013 – 2023 80
Chart 4 7: Leading Competitors, Implantable Port Market, India, 2016 84

Figure 1 1: Vascular Access Device and Accessories Market by Segment India, 2016 (1 of 2) 4
Figure 1 2: Vascular Access Device and Accessories Market by Segment India, 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, India, 2016 5
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, India 6
Figure 1 5: Recent Events in the Vascular Access Device and Accessories MarketIndia, 2012 – 2016 7
Figure 1 6: Vascular Access Device and Accessories Markets Covered, India, 2016 8
Figure 1 7: Key Report Updates 9
Figure 1 8: Version History 9
Figure 3 1: Class 2 Device Recall Medtronic 36
Figure 3 2: Class 2 Device Recall Smiths Medical 36
Figure 3 3: Class 2 Device Recall Arrow 37
Figure 3 4: Class 2 Device Recall Arrow 37
Figure 3 5: Class 2 Device Recall Covidien (Medtronic) 38
Figure 3 6: Class 2 Device Recall Arrow 39
Figure 3 7: Class 2 Device Recall Medline 39
Figure 3 8: Class 2 Device Recall Arrow 39
Figure 3 9: Class 2 Device Recall B. Braun 39
Figure 3 10: Class 3 Device Recall Bard Access 40
Figure 3 11: Class 2 Device Recall Covidien (Medtronic) 40
Figure 3 12: Class 2 Device Recall Bard Access 42
Figure 3 13: Class 2 Device Recall Bard Access 42
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics 43
Figure 3 15: Class 2 Device Recall Bard Access 43
Figure 3 16: Class 2 Device Recall Arrow 44
Figure 3 17: Class 2 Device Recall Medcomp 44
Figure 3 18: Class 2 Device Recall Arrow 44
Figure 3 19: Class 2 Device Recall Arrow 45
Figure 3 20: Class 2 Device Recall Smiths Medical 45
Figure 3 21: Class 2 Device Recall PFM Medical 45
Figure 3 22: Class 2 Device Recall PFM Medical 45
Figure 3 23: Class 2 Device Recall Becton Dickinson 46
Figure 3 24: Class 2 Device Recall Arrow 46
Figure 3 25: Class 2 Device Recall Arrow 46
Figure 3 26: Class 2 Device Recall Navilyst Medical 46
Figure 3 27: Class 2 Device Recall Argon Medical 47
Figure 3 28: Class 2 Device Recall Arrow 48
Figure 3 29: Class 2 Device Recall Arrow 48
Figure 3 30: Class 2 Device Recall Arrow 49
Figure 3 31: Class 2 Device Recall Bard Access 49
Figure 3 32: Class 2 Device Recall Navilyst Medical 49
Figure 3 33: Class 2 Device Recall Bard Access 50
Figure 3 34: Class 2 Device Recall Smiths Medical 50
Figure 3 35: Class 2 Device Recall B. Braun 50
Figure 3 36: Class 2 Device Recall Smiths Medical 51
Figure 3 37: Class 2 Device Recall Access Scientific 51
Figure 3 38: Class 2 Device Recall Covidien (Medtronic) 51
Figure 3 39: Class 2 Device Recall Arrow 52
Figure 3 40: Class 2 Device Recall Bard Access 52
Figure 3 41: Class 2 Device Recall Becton Dickinson 52
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 53
Figure 3 43: Class 2 Device Recall Bard Access 53
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 53
Figure 3 45: Class 2 Device Recall Medcomp 54
Figure 3 46: Class 2 Device Recall Becton Dickinson 54
Figure 3 47: Class 3 Device Recall Bard Access 54
Figure 3 48: Class 2 Device Recall Medcomp 55
Figure 3 49: Class 1 Device Recall Arrow 55
Figure 3 50: Class 2 Device Recall Arrow 55
Figure 3 51: Class 2 Device Recall Vygon 55
Figure 3 52: Class 2 Device Recall Covidien (Medtronic) 56
Figure 3 53: Class 2 Device Recall Medcomp 57
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company 57
Figure 3 55: Class 2 Device Recall Christie Medical Holdings 57
Figure 3 56: Class 3 Recall Bard Access 57
Figure 3 57: Class 2 Device Recall AngioDynamics 58
Figure 3 58: Class 2 Device Recall Becton Dickinson 58
Figure 3 59: Class 2 Device Recall AngioDynamics 58
Figure 3 60: Class 2 Device Recall AngioDynamics 60
Figure 3 61: Class 3 Device Recall AngioDynamics 61
Figure 3 62: Class 2 Device Recall AngioDynamics 61
Figure 3 63: Bone Anchored Port - a Novel Vascular Access for Hemodialysis Treatment 63
Figure 3 64: A Pragmatic Randomized Trial 63
Figure 3 65: Assessment of a Power Injectable vs. a Non-Power Injectable 64
Figure 3 66: Vascular Access in Cancer Patients 64
Figure 3 67: Ultrasound-guided Subclavian Vein Puncture Versus Cephalic Vein Dissection 64
Figure 4 1: Implantable Port Market by Segment, India, 2013 – 2023 (US$M) 72
Figure 4 2: Implantable Port Market by Segment, India, 2013 – 2023 (IN?M) 72
Figure 4 3: Total Implantable Port Market, India, 2013 – 2023 75
Figure 4 4: Conventional Implantable Port Market, India, 2013 – 2023 77
Figure 4 5: Power-Injectable Implantable Port Market, India, 2013 – 2023 79
Figure 4 6: Drivers and Limiters, Implantable Port Market, India, 2016 82
Figure 4 7: Leading Competitors, Implantable Port Market, India, 2016 84
Figure 6 1: Press Release Summary 86

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology